Fortis Malar Hospitals (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Fortis Malar Hospitals Limited |
|||
|
Price: ₹59.29 | ||
| 52 Week Low: ₹44.00 52 Week High: ₹107.94 |
|||
| Market Capital: 97.81 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Fortis Malar Hospitals Share Price Target For 2024
- 1.1.1: Fortis Malar Hospitals Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Fortis Malar Hospitals Share Price Target For 2025
- 1.2.1: Fortis Malar Hospitals Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Fortis Malar Hospitals Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Fortis Malar Hospitals Financial Performance
- 3.0.1: Is Fortis Malar Hospitals A Good Buy For Long Term?
To predict the Fortis Malar Hospitals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Fortis Malar Hospitals Share Price Target For 2024
The line chart displays the monthly closing prices of Fortis Malar Hospitals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Fortis Malar Hospitals shares in 2024, see the table below.
Fortis Malar Hospitals Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 62.3 (+5.07%) | Price Action: 10 Dec 2024 Low |
| 2024 Target 2 | 61.61 (+3.91%) | Fibonacci Extension Level 23.60% |
| 2024 Target 1 | 60.96 (+2.81%) | Price Action: 17 Dec 2024 Low |
| Current Price | 59.29 | Fortis Malar Hospitals's share price as of 23 Dec 2024 |
| Stop Loss 1 | 58.51 (-1.32%) | Price Action: May 2024 Low |
| Stop Loss 2 | 57.92 (-2.31%) | Price Action: Chart |
| Stop Loss 3 | 56.43 (-4.83%) | Technical Indicator: MA50 |
Short-Term Technical Outlook
Current Technical Position: Fortis Malar Hospitals is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹58.61 serves as the nearest technical reference point.
Historical Returns: 3-month: +0.03% | 6-month: -3.98% | 1-year: +65.81%
Fortis Malar Hospitals Share Price Target For 2025
The line chart displays the monthly closing prices of Fortis Malar Hospitals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Fortis Malar Hospitals shares in 2025, see the table below.
Fortis Malar Hospitals Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 101.65 (+71.44%) | Price Action: Chart |
| 2025 Target 2 | 99.75 (+68.23%) | Fibonacci Extension Level 123.60% |
| 2025 Target 1 | 97.68 (+64.73%) | Fibonacci Extension Level 64.90% |
| Current Price | 59.29 | Fortis Malar Hospitals's share price as of 23 Dec 2024 |
| Stop Loss 1 | 43.32 (-26.94%) | Fibonacci Retracement Level 71.80% |
| Stop Loss 2 | 42.89 (-27.67%) | Price Action: Chart |
| Stop Loss 3 | 42.12 (-28.96%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Fortis Malar Hospitals is currently trading near its 52-week low of ₹44, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: +65.81% | 3-year: +51.18% | 5-year: +103.3%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Fortis Malar Hospitals Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹59.29 | ||
| 2024 | ₹54.80 | -7.57% | ₹55.62 |
| 2025 | ₹48.70 | -11.13% | ₹53.84 |
| 2026 | ₹41.27 | -15.25% | ₹47.48 |
| 2027 | ₹37.25 | -9.74% | ₹40.60 |
| 2028 | ₹33.76 | -9.36% | ₹38.22 |
| 2029 | ₹39.00 | +15.52% | ₹43.78 |
| 2030 | ₹35.78 | -8.25% | ₹38.86 |
| 2031 | ₹38.24 | +6.87% | ₹41.44 |
| 2032 | ₹41.20 | +7.74% | ₹41.82 |
| 2033 | ₹59.76 | +45.04% | ₹62.68 |
| 2034 | ₹62.78 | +5.05% | ₹65.66 |
| 2035 | ₹64.92 | +3.4% | ₹65.89 |
| 2036 | ₹62.87 | -3.15% | ₹65.87 |
| 2037 | ₹65.98 | +4.94% | ₹66.97 |
| 2038 | ₹60.15 | -8.83% | ₹65.13 |
| 2039 | ₹66.08 | +9.85% | ₹67.07 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Fortis Malar Hospitals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 97.81 Crore | Market valuation of Fortis Malar Hospitals's shares. |
| Revenue (TTM) | 58.85 Crore | Total revenue generated by Fortis Malar Hospitals over the past twelve months. |
| Net Income (TTM) | +45.32 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +92.28% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +85.09% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-100% | Change in revenue compared to the previous quarter. |
| Total Cash | 73.48 Lakh | Total amount of liquid funds available to Fortis Malar Hospitals. |
Is Fortis Malar Hospitals A Good Buy For Long Term?
Fortis Malar Hospitals, a small-cap stock with a market capitalization of ₹97.81 crore, shows mixed signals. While it boasts a high profit margin of 85.09% and a substantial net profit of ₹45.32 crore (TTM), its recent performance is concerning. Negative returns over the past 3, 6, and 12 months (-17.76%, -41.74%, -33.01% respectively) and a low cash balance of ₹73.48 lakh (Q1 2024-25) raise red flags. Considering the substantial negative returns, it's not a good buy for the long term at this time. Further investigation into the cause of the revenue drop (-100% QoQ) is crucial before considering investment.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
